wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34439059-22E9113D-570D-480B-8DB8-60D37455F86B
Q34439059-22E9113D-570D-480B-8DB8-60D37455F86B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34439059-22E9113D-570D-480B-8DB8-60D37455F86B
Is progression-free survival associated with a better health-related quality of life in patients with lung cancer? Evidence from two randomised trials with afatinib.
P2860
Q34439059-22E9113D-570D-480B-8DB8-60D37455F86B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34439059-22E9113D-570D-480B-8DB8-60D37455F86B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ff6ff09cc7c6510f881e6a702257506e78c589f9
P2860
Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial.